PharmaShots | Incisive News in 3 Shots

Subscribe Now

Infantile Neuroaxonal Dystrophy

Retrotope's RT001 Receives EMA's Orphan Drug Designation for Infantile Neuroaxonal Dystrophy (INAD)

Retrotope's RT001 Receives EMA's Orphan Drug Designation for Infantile Neuroaxonal Dystrophy (INAD)

March 14, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us